anti human muc16 alexa fluor 594 (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
94
Structured Review
R&D Systems
anti human muc16 alexa fluor 594
Anti Human Muc16 Alexa Fluor 594, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+ca125/Human+CA125%2FMUC16+Alexa+Fluor%C2%AE+594-conjugated+Antibody/pmc12972391-72-50-54
Average 94 stars, based on 1 article reviews
Anti Human Muc16 Alexa Fluor 594, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+ca125/Human+CA125%2FMUC16+Alexa+Fluor%C2%AE+594-conjugated+Antibody/pmc12972391-72-50-54
Average 94 stars, based on 1 article reviews
anti human muc16 alexa fluor 594 - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
Blocking Assay:Article Title: Establishment of Novel High-Grade Serous Ovarian Carcinoma Cell Line OVAR79. Article Snippet: Cells were detached using 0.05% trypsin, washed three times with PBS, and fixed with 4% paraformaldehyde (Sigma-Aldrich, St. Louis, MO, USA). .. The cells were then placed in a serum-free protein block solution ((Dako/Agilent Technologies, San Diego, CA, USA) and incubated with primary antibodies—anti-CD324 (E-cadherin; Sony, Tokyo, Japan, #1336505), anti-EpCAM (Abcam, Cambridge, UK, ab223582), anti-CD44 (BD Biosciences, Franklin Lakes, NJ, USA, #2294010), anti-PanCK (Eagle BioSciences, Amherst, NH, USA, 10- 310015-01), Article Title: Establishment of Novel High-Grade Serous Ovarian Carcinoma Cell Line OVAR79 Article Snippet: Cells were detached using 0.05% trypsin, washed three times with PBS, and fixed with 4% paraformaldehyde (Sigma-Aldrich, St. Louis, MO, USA). .. The cells were then placed in a serum-free protein block solution ((Dako/Agilent Technologies, San Diego, CA, USA) and incubated with primary antibodies—anti-CD324 (E-cadherin; Sony, Tokyo, Japan, #1336505), anti-EpCAM (Abcam, Cambridge, UK, ab223582), anti-CD44 (BD Biosciences, Franklin Lakes, NJ, USA, #2294010), anti-PanCK (Eagle BioSciences, Amherst, NH, USA, 10-310015-01), Incubation:Article Title: Establishment of Novel High-Grade Serous Ovarian Carcinoma Cell Line OVAR79. Article Snippet: Cells were detached using 0.05% trypsin, washed three times with PBS, and fixed with 4% paraformaldehyde (Sigma-Aldrich, St. Louis, MO, USA). .. The cells were then placed in a serum-free protein block solution ((Dako/Agilent Technologies, San Diego, CA, USA) and incubated with primary antibodies—anti-CD324 (E-cadherin; Sony, Tokyo, Japan, #1336505), anti-EpCAM (Abcam, Cambridge, UK, ab223582), anti-CD44 (BD Biosciences, Franklin Lakes, NJ, USA, #2294010), anti-PanCK (Eagle BioSciences, Amherst, NH, USA, 10- 310015-01), Article Title: Improving SERS biosensors for the analysis of ovarian cancer-derived small extracellular vesicles. Article Snippet: Small extracellular vesicles (sEVs) are lipid bilayer vesicles that carry key molecules (e.g., proteins, DNAs, RNAs, and lipids) for cell-to-cell communication, being regarded as promising biomarkers for cancer diagnosis.. However, the detection of sEVs is still challenging due to their unique characteristics such as size and phenotype heterogeneity.. The surface-enhanced Raman scattering (SERS) assay is a promising tool for sEV analysis as it shows the advantages of robustness, high sensitivity, and specificity. Article Title: Establishment of Novel High-Grade Serous Ovarian Carcinoma Cell Line OVAR79 Article Snippet: Cells were detached using 0.05% trypsin, washed three times with PBS, and fixed with 4% paraformaldehyde (Sigma-Aldrich, St. Louis, MO, USA). .. The cells were then placed in a serum-free protein block solution ((Dako/Agilent Technologies, San Diego, CA, USA) and incubated with primary antibodies—anti-CD324 (E-cadherin; Sony, Tokyo, Japan, #1336505), anti-EpCAM (Abcam, Cambridge, UK, ab223582), anti-CD44 (BD Biosciences, Franklin Lakes, NJ, USA, #2294010), anti-PanCK (Eagle BioSciences, Amherst, NH, USA, 10-310015-01), Concentration Assay:Article Title: Improving SERS biosensors for the analysis of ovarian cancer-derived small extracellular vesicles. Article Snippet: Small extracellular vesicles (sEVs) are lipid bilayer vesicles that carry key molecules (e.g., proteins, DNAs, RNAs, and lipids) for cell-to-cell communication, being regarded as promising biomarkers for cancer diagnosis.. However, the detection of sEVs is still challenging due to their unique characteristics such as size and phenotype heterogeneity.. The surface-enhanced Raman scattering (SERS) assay is a promising tool for sEV analysis as it shows the advantages of robustness, high sensitivity, and specificity. Control:Article Title: Improving SERS biosensors for the analysis of ovarian cancer-derived small extracellular vesicles. Article Snippet: Small extracellular vesicles (sEVs) are lipid bilayer vesicles that carry key molecules (e.g., proteins, DNAs, RNAs, and lipids) for cell-to-cell communication, being regarded as promising biomarkers for cancer diagnosis.. However, the detection of sEVs is still challenging due to their unique characteristics such as size and phenotype heterogeneity.. The surface-enhanced Raman scattering (SERS) assay is a promising tool for sEV analysis as it shows the advantages of robustness, high sensitivity, and specificity. In Vitro:Article Title: Improving SERS biosensors for the analysis of ovarian cancer-derived small extracellular vesicles. Article Snippet: Small extracellular vesicles (sEVs) are lipid bilayer vesicles that carry key molecules (e.g., proteins, DNAs, RNAs, and lipids) for cell-to-cell communication, being regarded as promising biomarkers for cancer diagnosis.. However, the detection of sEVs is still challenging due to their unique characteristics such as size and phenotype heterogeneity.. The surface-enhanced Raman scattering (SERS) assay is a promising tool for sEV analysis as it shows the advantages of robustness, high sensitivity, and specificity. Suspension:Article Title: Improving SERS biosensors for the analysis of ovarian cancer-derived small extracellular vesicles. Article Snippet: Small extracellular vesicles (sEVs) are lipid bilayer vesicles that carry key molecules (e.g., proteins, DNAs, RNAs, and lipids) for cell-to-cell communication, being regarded as promising biomarkers for cancer diagnosis.. However, the detection of sEVs is still challenging due to their unique characteristics such as size and phenotype heterogeneity.. The surface-enhanced Raman scattering (SERS) assay is a promising tool for sEV analysis as it shows the advantages of robustness, high sensitivity, and specificity. |